NO308253B1 - Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne - Google Patents

Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne

Info

Publication number
NO308253B1
NO308253B1 NO960123A NO960123A NO308253B1 NO 308253 B1 NO308253 B1 NO 308253B1 NO 960123 A NO960123 A NO 960123A NO 960123 A NO960123 A NO 960123A NO 308253 B1 NO308253 B1 NO 308253B1
Authority
NO
Norway
Prior art keywords
pct
fluorochrome
fluorochromes
making
fluorescent latex
Prior art date
Application number
NO960123A
Other languages
English (en)
Norwegian (no)
Other versions
NO960123L (no
NO960123D0 (no
Inventor
Sophie Vaslin
Joul Richard
Dominique Teychenne
Frederic Ricchiero
Dan Lerner
Original Assignee
Prolabo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolabo Sa filed Critical Prolabo Sa
Publication of NO960123D0 publication Critical patent/NO960123D0/no
Publication of NO960123L publication Critical patent/NO960123L/no
Publication of NO308253B1 publication Critical patent/NO308253B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/10—Encapsulated ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Luminescent Compositions (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO960123A 1993-07-12 1996-01-11 Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne NO308253B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9308573A FR2707658B1 (fr) 1993-07-12 1993-07-12 Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie.
PCT/FR1994/000867 WO1995002635A1 (fr) 1993-07-12 1994-07-11 Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application

Publications (3)

Publication Number Publication Date
NO960123D0 NO960123D0 (no) 1996-01-11
NO960123L NO960123L (no) 1996-03-12
NO308253B1 true NO308253B1 (no) 2000-08-21

Family

ID=9449186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960123A NO308253B1 (no) 1993-07-12 1996-01-11 Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne

Country Status (10)

Country Link
US (1) US5716855A (ja)
EP (1) EP0712426B1 (ja)
JP (1) JPH09504041A (ja)
CA (1) CA2167072C (ja)
DE (1) DE69403663T2 (ja)
DK (1) DK0712426T3 (ja)
ES (1) ES2104405T3 (ja)
FR (1) FR2707658B1 (ja)
NO (1) NO308253B1 (ja)
WO (1) WO1995002635A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578498A (en) 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
JP3338616B2 (ja) * 1996-09-05 2002-10-28 富士通株式会社 蛍光体層の形成方法及び蛍光体ペースト
KR20010031140A (ko) 1997-10-14 2001-04-16 루미넥스 코포레이션 정밀 형광염료 입자 및 그의 제조방법 그리고 그의 사용
JP2002504689A (ja) 1998-02-18 2002-02-12 デイド・ベーリング・インコーポレイテッド 複数の検体の検出において使用するための化学ルミネセンス組成物
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
IL141759A0 (en) * 1998-09-03 2002-03-10 Trellis Bioinformatics Inc Multihued labels
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
WO2005003182A2 (en) * 2003-07-02 2005-01-13 Perkinelmer Las, Inc. Scintillator composition for a radioassay, and method for its use
US7407816B2 (en) * 2004-05-07 2008-08-05 Gentius, Inc Isoelectric particles and uses thereof
EP1792187A1 (en) * 2004-09-10 2007-06-06 Philips Intellectual Property & Standards GmbH Compounds and methods for combined optical-ultrasound imaging
WO2006115870A2 (en) * 2005-04-20 2006-11-02 Becton Dickinson And Company Multiplex microparticle system
US7939613B2 (en) * 2005-04-22 2011-05-10 The Hong Kong University Of Science And Technology Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
NO20053373D0 (no) * 2005-07-11 2005-07-11 Rikshospitalet Radiumhospitale Multicolored Particles.
EP2393851B1 (en) 2009-02-09 2018-02-28 Merck Patent GmbH Coloured particles for electrophoretic displays
EP2393848A1 (en) 2009-02-09 2011-12-14 Merck Patent GmbH Coloured particles for electrophoretic displays
JP5902481B2 (ja) 2009-02-09 2016-04-13 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 電気泳動ディスプレイのための粒子
WO2010089059A1 (en) 2009-02-09 2010-08-12 Merck Patent Gmbh Coloured particles for electrophoretic displays
GB2475226A (en) * 2009-11-03 2011-05-18 Genetic Analysis As Universal Prokaryote 16S ribosome PCR primer pair
GB201021399D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
GB201021397D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Diagnosis of Crohn's disease
GB201102693D0 (en) 2011-02-16 2011-03-30 Genetic Analysis As Method for identifying neonates at risk for necrotizing enterocolitis
US9227181B2 (en) 2011-09-13 2016-01-05 Basf Corporation Catalyst to increase propylene yields from a fluid catalytic cracking unit
EP2984114B1 (en) 2013-04-12 2017-03-15 Merck Patent GmbH Particles for electrophoretic displays
EP3233944B1 (en) 2014-12-19 2019-09-04 Merck Patent GmbH Particles for electrophoretic displays
JPWO2018043687A1 (ja) * 2016-08-31 2019-08-15 積水化学工業株式会社 診断薬用蛍光粒子及びそれを用いた免疫測定試薬
CN111363539A (zh) * 2020-04-30 2020-07-03 上海思滤科技有限公司 一种单分散多色发光微球及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US5073497A (en) * 1989-06-30 1991-12-17 Caribbean Microparticles Corporation Microbead reference standard and method of adjusting a flow cytometer to obtain reproducible results using the microbeads
DE3850981T2 (de) * 1987-02-27 1995-03-30 Eastman Kodak Co Wasserunlösliches Teilchen und immunoreaktives Reagens, analytische Elemente und Verfahren zu ihrer Verwendung.
US5607864A (en) * 1992-04-07 1997-03-04 Societe Prolabo Fluorescent latices having very low detection thresholds for fluorescent emission
US5264960A (en) * 1992-05-08 1993-11-23 At&T Bell Laboratories Optical wavelength shifter
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5393527A (en) * 1993-01-04 1995-02-28 Becton, Dickinson And Company Stabilized microspheres and methods of preparation

Also Published As

Publication number Publication date
JPH09504041A (ja) 1997-04-22
EP0712426A1 (fr) 1996-05-22
DE69403663T2 (de) 1998-01-02
US5716855A (en) 1998-02-10
ES2104405T3 (es) 1997-10-01
WO1995002635A1 (fr) 1995-01-26
CA2167072C (fr) 2008-10-28
DK0712426T3 (da) 1997-12-22
CA2167072A1 (fr) 1995-01-26
NO960123L (no) 1996-03-12
DE69403663D1 (de) 1997-07-10
EP0712426B1 (fr) 1997-06-04
NO960123D0 (no) 1996-01-11
FR2707658B1 (fr) 1995-11-24
FR2707658A1 (fr) 1995-01-20

Similar Documents

Publication Publication Date Title
NO308253B1 (no) Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne
US5657255C1 (en) Hierarchic biological modelling system and method
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ES2164794T3 (es) Dna que codifica cd 19.
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
CO4480111A1 (es) Anticuerpos monoclonales de mono especificos para humanos b7. y/o b7.2, formas primatizadas de los mismos, composicio- nes farmaceuticas que los contienen, y uso de los mismos co- mo inmunosupresantes
DE69632949D1 (de) Die aktivierung von rezeptoren durch gas6
ATE103315T1 (de) Verwendung haertbarer cycloaliphaten-derivate in duebelmassen.
DE69231644T2 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
DE3870268D1 (de) Vorrichtung zur sterilisation durch ultraviolettes licht.
DE59009101D1 (de) Lichtlenksystem für die beleuchtung eines innenraums.
ATE360715T1 (de) Faser oder filament
AU6767090A (en) Process for the optical distinction of a dental material and dental material for said process
DE69403319D1 (de) Strahlungsinduzierte fixierung von farbstoffen
AU5994386A (en) Bone cement
ES2069846T3 (es) Procedimiento de tratamiento de una señal video.
IT8022361A0 (it) Fosforo alluminato emettitore di raggi ultravioletti e lampade fluorescenti per l'abbronzatura artificiale utilizzanti tale fosforo.
UA27771C2 (uk) Електролітична комірка (варіанти) та спосіб мічення протеїнів, пептидів і інших органічних молекул
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
WO2003107545A3 (en) TECHNIQUES FOR IDENTIFYING COMPOUNDS FOR TREATING PATHOLOGICAL CONDITIONS
ATE92954T1 (de) Einrichtung zum kultivieren von autotrophen mikroorganismen.
NO971325L (no) Fremgangsmåte for fremstilling av 3,4-dihydroksy-5-nitrobenzaldehyd
Starks The scombroid fishes

Legal Events

Date Code Title Description
MK1K Patent expired